Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenobarbital versus levetiracetam in children with febrile seizures
IRCT20221105056406N1Phase 2Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Nov 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in febrile seizure (FS) comparing Phenobarbital with Levetiracetam (2 arms). Primary endpoints: Presence or absence of seizures, Amount of seizures and 7 more. Started Nov 2022; status: completed.
02
Drugs
phenobarbitallevetiracetam
03
Conditions
febrile seizure (FS)
Beyond the preview
Go deeper on IRCT20221105056406N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221105056406N1.